Matches 51 - 100 out of 297 < 1 2 3 4 5 6 >
Match Document Document Title
6524604 Method, composition and kit to remove lice ova from the hair  
A composition for removal of lice ova or nits from the hair of human subjects comprises about 1-50% by weight of dimethylisosorbide (DMI) in an aqueous vehicle having a neutral to acidic pH. The...
6518291 Inhibitors of IMPDH enzyme  
The present invention relates to a novel class of compounds which are IMPDH inhibitors. This invention also relates to pharmaceutical compositions comprising these compounds. The compounds and...
6515020 Combination of carnitines and resveratrol for prevention or treatment of cerebral and ageing disorders  
A pharmaceutical product which comprises admixed or separately packaged (A) L-Carnitine or an alkanoyl L-canitine and (B) a trihydroxy- or tetrahydroxystilbene such as resveratrol is useful for the...
6514979 Synergistic combinations of guanosine analog reverse transcriptase inhibitors and inosine monophosphate dehydrogenese inhibitors and uses therefor  
Synergistic combinations of guanosine nucleoside analog reverse transcriptase inhibitors such as abacavir with inosine monophosphate dehydrogenase inhibitors such as mycophenolates, pharmaceutical...
6492374 Benzofuran derivatives, their preparation and use  
The present invention relates to benzofuran derivatives having general Formula (I) wherein A is selected from (1), (2), (3), (4) wherein Z is O or S; s is 0 or 1; q is 0 or 1; R 4 is hydrogen,...
6489365 Amidine derivatives, the preparation and use thereof as medicaments with Itb4 antagonistic effect  
Compounds of the formula which is explained more fully in the specification, may be prepared by conventional methods and used therapeutically in conventional galenic preparations.
6489357 Tobacco cembranoids block the expression of the behavioral sensitization to nicotine and inhibit neuronal acetylcholine receptors  
The subject invention relates the use of cembranoids to inhibit nicotine addiction at the behavioral level. The subject host is sensitized to nicotine. Cembranoids are then administered to reduce...
6472406 Sulfonamidomethyl phosphonate inhibitors of beta-lactamase  
The intention relates to bacterial antibiotic resistance and, in particular, to compositions and methods for overcoming bacterial antibiotic resistance. The invention provides novel β-lactamase...
6469054 Aryl sulphonamides and analogues  
The present invention relates to novel arylsulphonamides and analogues, to processes for their preparation and to their use for the prophylaxis and treatment of neurodegenerative disorders, in...
6465463 Methods of treating and preventing congestive heart failure with hydralazine compounds and isosorbide dinitrate or isosorbide mononitrate  
The present invention provides methods or treating and preventing mortality associated with heart failure in an African American patient with hypertension and improving oxygen consumption, quality...
6462055 Alpha-methylbenzyl-containing thiourea inhibitors of herpes viruses containing a phenylenediamine group  
Compounds having the formula: wherein R 1 -R 5 are independently selected from hydrogen, alkyl of 1 to 6 carbon atoms, alkenyl of 2 to 6 carbon atoms, alkynyl of 2 to 6 carbon atoms,...
6458825 Lactacystin analogs  
Compounds related to lactacystin and lactacystin lactone, pharmaceutical compositions containing the compounds, and methods of use.
6451844 Use of menthyl-2 pyrrolidone-5-carboxylate as an insect repellent  
The use of menthyl 2-pyrrolidone-5-carboxylate as an insect repellent, usually by application to a substrate or into an air space. The menthyl 2-pyrrolidone-5-arboxylate can be used as a...
6436447 Evacuant  
Disclosed is an evacuant possessing a sufficient evacuating effect in a small dose substantially without accompanying any irritation to bowel, irrespective of whether its preparations are in the...
6433004 Substituted β,&ggr -anellated lactones  
The present invention relates to novel substituted β,γ-fused lactones, to processes for their preparation and to their use for the prevention and/or treatment of disorders caused by hyper- or...
6433005 Benzofuran and benzothiophene derivatives as anti-inflammatory agents  
This invention relates to compounds, which are generally anti-inflammatory and analgesic compounds, and which are represented by Formula I: wherein A is a —CH 2 —, —C(O)—, —O—,...
6420427 Aminobutyric acid derivatives  
An aminobutyric acid derivative of the formula (I): (wherein all symbols are as defined in the specification) and salt thereof. salt thereof. The compounds of the formula (I) possess an...
6420418 Heterocycle amides as cell adhesion inhibitors  
Compounds of Formula I are antagonists of VLA-4 and/or α4β7, and as such are useful in the inhibition or prevention of cell adhesion and cell-adhesion mediated pathologies. These compounds may be...
6407100 Fungicidal aromatic oximes  
The invention relates to novel compounds of the formula in which R 1 is C 1-4 alkyl and (Y—X) is CH 2 , C 1-2 alkylthio-CH═ or C 1-2 alkyl-ON═ and Z is an aldimino or ketimino group, and...
6391365 Use of 3,6-dimethyl-2(3H)-benzofuranone as flavor material and new process for its preparation  
3,6-Dimethyl-2(3H)-benzofuranone is a new, valuable flavor material. A process for its industrial-scale preparation was developed.
6376539 Substituted bicyclic lactones  
The present invention relates to novel substituted bicyclic lactones, to processes for their preparation and to their use for the prevention and/or treatment of disorders caused by hyper- or...
6358998 Body fat-reducing agent comprising dioxabicyclo&lsqb 3.3.0&rsqb octane derivative as active ingredient  
There is provided an agent for reducing body fat, comprising as an active ingredient a dioxabicyclo[3.3.0]octane derivative represented by formula (I): wherein R 1 to R 6 each independently...
6355634 Aromatic compounds  
The invention relates to novel compounds of the formula in which R 1 is C 1-4 alkyl and (Y—X) is CH 2 , C 1-2 alkylthio-CH═ or C 1-2 alkyl-ON═ and Z is an aldimino or ketimino group, and...
6323199 Nonsteroidal anti-inflammatory agents  
This invention describes the use of the compounds of general formula I ##STR1## in which A, B, A, Ar, R 1 , R 2 and R 3 have the meaning that is indicated in more detail in the description, for...
6306900 Enteric coated pharmaceutical compositions  
This invention provides a pharmaceutical composition comprising a mycophenolate salt, the composition being adapted to release mycophenolate in the upper part of the intestinal tract.
6302837 Benzothiophene, benzofuran and indole compounds  
A compound selected from those of formula (I): ##STR1## wherein: X represents oxygen, sulphur, or NR 3 wherein R 3 is as defined in the description, Y represents oxygen, sulphur, NR 3 , or...
6284790 Methods of potentiating organic nitrates having vasodilating activity and formulations for the same  
A method for potentiating an organic nitrate having vasodilating activity by administering to a subject an effective amount of the organic nitrate with a potentiating amount of a thromboxane...
6281240 Diarylsulfonylureas for use in treating secretory diarrhea  
This invention provides methods of treating secretory diarrhea or cystic fibrosis in a mammal which comprises administering to a mammal in need thereof an effective amount of diarylsulfonylurea....
6277846 Use of platelet activating factor antagonists as anti-pruritic agents  
The invention relates to a method for treating pruritus by administering a therapeutically effective amount of a PAF antagonist to a mammal afflicted with pruritus. The PAF antagonists may, for...
6277874 Methods for the treatment of apolipoprotein E related diseases  
Methods for treating diseases associated with toxicity of Apolipoprotein E ("apoE"). Specifically, the present invention relates to new methods for treating a mammal having a condition associated...
6271252 Cyclic amino acid derivatives as cell adhesion inhibitors  
Cyclic amino acid derivatives of Formula I are antagonists of VLA-4 and/or α 4 β 7 , and as such are useful in the inhibition or prevention of cell adhesion and cell-adhesion mediated...
6265428 Substituted phenyl compounds and derivatives thereof that modulate the activity of endothelin  
Methods, compositions, and compounds for modulating the activity of an endothelin peptide are provided. The methods use compositions that contain compounds of formula (1): ##STR1## where X and Y...
6204289 Cembranoid inhibitors of nicotinic acetylcholine receptors  
The present invention relates to the use of cembranoids to inhibit nicotinic acetylcholine receptors.
6200989 2-alkylidene hydroxycumaranone derivatives  
Compounds of the formula ##STR1## wherein R,R', A,B,T and x have the meaning given in the specification possess uPA (urokinase-type plasminogen activator) antagonist activity and can be employed as...
RE37087 Insecticidal triffluormethyl alkane derivatives  
There are provided new alkane and alkoxyalkane derivatives of the general formula I ##STR1## in which R 1 , R 2 , R 3 , R 4 and A have the meanings given in the description, processes for their...
6197790 Benzothiophene compounds, intermediates, compositions, and methods  
A method for alleviating the symptoms of post-menopausal syndrome comprising administering to a woman in need thereof an effective amount of a compound of formula I ##STR1## wherein R 1a is --H...
6172107 Entric-coated pharmaceutical compositions  
This invention provides a pharmaceutical composition comprising a mycophenolate salt, the composition being adapted to release mycophenolate in the upper part of the intestinal tract.
6153645 Heterocycles as antimicrobial agents  
Methods for treating infection and related compositions, compounds of formula I as defined in the application and methods for preparing same, are provided. In general, the compounds inhibit...
6147110 Heterocyclic compounds  
Compound of formula (I): ##STR1## wherein: B represents optionally substituted (C 1 -C 6 )-alkylene, W represents oxygen or sulphur, R represents hydrogen, hydroxy, R', or OR', R' being as...
6143779 Benzofuranone derivatives and a method for producing them  
The present invention provides new benzofuranone derivatives and a method for producing the derivatives useful for a therapeutic agent for preventing and/or treating hormone dependent diseases. The...
6139821 Materials and methods utilizing a temporary visual indicator  
This invention relates to novel compositions containing temporary visual indicators and methods for using these compositions. Specifically, this invention relates to a sunscreen composition...
6140315 Therapeutic uses of goserelin acetate  
A method of decreasing atherosclerosis and its complications, such as myocardial infarction, stroke and peripheral vascular disease, wherein the method involves administering to a human or an...
6099868 Method of using potassium nitrate for pain reduction  
A method of anesthetizing a tooth requiring tooth preparation, caries removal or manual manipulation thereof is disclosed. The method includes the steps of applying a composition having a high...
6080782 Cyclohexyl dihydrobenzofuranes  
6075044 Heterocyclic derivatives as inhibitors of purine salvage phosphoribosyltransferases  
The use of certain heterocyclic derivatives for treating parasitic protozoa infections in mammals, in particular bovine trichomoniasis and giardiasis, is disclosed.
6060075 Check mite composition and a process for preparing the same  
This invention relates to a composition for controlling house dust mites. The composition comprises neem seed kernel extract containing azadirachtin, an alcoholic extract of plant resins, plant...
6034120 Insect antifeedant for agriculture  
The present invention provides an antifeedant and a contact insecticide using the components contained in Cyperaceae species. In particular, the present invention provides an insect antifeedant and...
6034073 Solvent detergent emulsions having antiviral activity  
Methods and pharmaceutical compositions for inactivating an envelope virus using an oil-in-water emulsion including an oil, a surfactant, and an organic phosphate-based solvent are disclosed. These...
6025391 Enteric-coated pharmaceutical compositions of mycophenolate  
5990160 Use of tropolone derivatives as inhibitors of the enzyme inositol monophosphatase  
The present invention concerns the use of puberulic or puberulonic acid as inhibitors of the enzyme iositol monophosphatase (EC 3.1.3.25) and thus useful in the treatment of manic or depressive...
Matches 51 - 100 out of 297 < 1 2 3 4 5 6 >